PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHypotension
MeSH D007022 - hypotension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014652:Vascular diseases
$
Success rate
D007022: 
Hypotension
D007024:Orthostatic hypotension
$
Success rate
D012791:Shy-drager syndrome
0 Companies
0 Drugs
Success rate
D057774:Post-exercise hypotension
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDopamine Dopamine  1991-10-23   
Epinephrine Epinephrine  2018-08-16   
MylanEpinephrine Epi 2025-09-11 1987-12-22   
Norepinephrine Norepinephrine  2018-10-04   
PerrigoIbuprofen, Phenylephrine Ibuprofen Phenylephrine  2014-07-03   
GSKIbuprofen, Phenylephrine, Chlorpheniramine Advil  2011-12-21   
Armstrong PharmaceuticalsEpinephrine Epinephrine  1984-05-23   
Epinephrine Primatene Mist 2026-01-26 2018-11-07   
Lupin ResearchPhenylephrine, Ketorolac tromethamine Ketorolac Tromethamine Phenylephrine  2019-07-01   
SandozNorepinephrine Norepinephrine  2018-10-18   
Phenylephrine Phenylephrine  2019-01-31   
AstraZenecaPrilocaine, Epinephrine Citanest  1982-01-01   
Epinephrine, Etidocaine Duranest  1982-01-01   
Lidocaine, Epinephrine Xylocaine W/ Epinephrine  1982-01-01   
WyethEpinephrine Bronitin Mist  1982-01-01   
Sterling WinthropEpinephrine Bronkaid Mist  1982-01-01   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
83%
15/18
Phase 2
51%
18/35
Phase 3
69%
22/32
Approved: 8Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use